Watson Pharmaceuticals Incorporated
WPI:NYSE
| Last | Change / % Change | Dividend Yield | Volume |
| 51.87 | -0.4400 -0.84% | 0.00% | 1,084,448 |
Market data is delayed by at least 20 minutes.
Exclusive Features
When you open a Scottrade account, you will be able to trade, add stocks to a watch list, set alerts and get real-time quotes.
For full analysis details, Log In with Scottrade or you can:
Latest News Headlines for Watson Pharmaceuticals Incorporated
Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile
Reportlinker.com announces that a new market research report is available in its catalogue:
Watson Pharmaceuticals Inc.: PharmaVitae Profile
http://www.reportlinker.com/p0171756/Watson-Pharmaceuticals-Inc-PharmaVitae-Profile.html
Watson Pharmaceuticals Sees Earnings Above Estimates
Watson Pharmaceuticals, Inc. (NYSE: WPI) said it expects 2010 earnings to be at, or slightly above, the mid-point of its previous guidance range of $3.37 to $3.45 per share. The current consensus earnings estimate is $3.40 per share for the year ending December 31, 2010.
Watson Announces Preliminary Financial Performance for FY 2010
View more recent headlinesAt the 29th Annual J.P. Morgan Healthcare Conference, Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that based on a preliminary review of 2010 results, it expects net revenues to increase more than 25 percent to more than $3.5 billion compared to 2009. Adjusted cash earnings per share is expected to be at or slightly above the midpoint of the company's latest forecast of $3.37 to $3.45 per share, a greater than 12 percent increase over 2009. This is based on a preliminary review of the Company's operating results for the fourth quarter and year-ended December 31, 2010.
Company Background
Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. Watson operates manufacturing, distribution, research and development (R&D;), and administrative facilities in the United States of America. Watson operates and manages its business as three operating segments: Generic, Brand and Distribution. As of December 31, 2009, the Company marketed approximately 170 generic pharmaceutical product families and 30 brand pharmaceutical product families and distributed approximately 8,000 stock-keeping units (SKUs) through its Distribution business in the United States. On December 2, 2009, Watson completed the acquisition of Robin Hood Holdings Limited and Cobalt Laboratories, Inc. On November 26, 2009, the Company acquired Arrow Group. Watson also acquired a 36% ownership interest in Eden Biopharm Group (Eden).
Bid/Size -- / -- | Ask/Size -- / -- |
Price Open 52.14 | Previous Close 52.31 |
Day High 52.20 | Day Low 51.39 |
52wk High/Date 53.75 / 1/11/2011 | 52wk Low/Date 37.26 / 2/12/2010 |
Beta 0.47 | Market Capitalization 7B |
Shares Outstanding 133M | Volatility Avg 21.39 |
Avg Vol(10 day) 1M | P/E Ratio 28.0x |
EPS (TTM) 2 | Annualized Rate -- / -- |
Yield 0.00% | Dividend Announcement -- |
Ex-Date -- | Date of Record -- |
Payable 0.00 - -- | Payable Date -- |
Last Trade as of 1/14/2011 4:03 PM ET | |
Exclusive Content
When you open an account with Scottrade, you will get premium content on the News & Content page, including:
- Standard & Poor's News and Commentary
- Dow Jones News
- Briefing News and Commentary
- Market Edge On the Edge Commentary
For full analysis details, Log In with Scottrade or you can:
WPI Watson Pharmaceuticals Incorporated vs. Peers
| Peers | |
WPI Watson Pharmaceuticals Incorporated | 0.43% |
| MYL Mylan Inc. | 7.90% |
| COV Covidien plc | 3.88% |
| MCK McKesson Corporation | 5.39% |
| ABC AmerisourceBergen Corp. | 3.84% |
WPI Watson Pharmaceuticals Incorporated | 0.00% |
| MYL Mylan Inc. | -- |
| COV Covidien plc | 1.69% |
| MCK McKesson Corporation | 0.97% |
| ABC AmerisourceBergen Corp. | 1.13% |
WPI Watson Pharmaceuticals Incorporated | -0.84% |
| MYL Mylan Inc. | 0.31% |
| COV Covidien plc | 0.23% |
| MCK McKesson Corporation | -0.31% |
| ABC AmerisourceBergen Corp. | 0.14% |